HCV New Drug Research: Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension
Links shared publicly online about this topic.
- 145total visits
HCV New Drug Research: Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension
hepatitiscnewdrugs.blogspot.com —
HCV New Drug Research: Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension
View full resource at hepatitiscnewdrugs.blogspot.com
Tags: Heart Disease, High Blood Pressure, Liver Condition, Cirrhosis, Drug
Most Recently Shared on July 15, 2011 at 12:32 pm By:
Tina Banwart - HepatitisCNewDrugs
HCV New Drug Research:clinical outcome in patients with cirrhosis and portal hypertension http://t.co/QsdOKQO
HCV New Drug Research: Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on July 15, 2011 at 1:36 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal… http://goo.gl/fb/KY6ak
Advertisement
